+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Human Rabies Vaccines Market by Cell Line Type (BHK Cells, Chick Embryo Cells, Vero Cell), Route of Administration (Intravenous, Subcutaneous), Application, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674553
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Rabies Vaccines Market size was estimated at USD 1.01 billion in 2023, USD 1.05 billion in 2024, and is expected to grow at a CAGR of 4.51% to reach USD 1.37 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Rabies Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Rabies Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Rabies Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bavarian Nordic A/S, Bharat Biotech International Limited, Cadila Pharmaceuticals Ltd., CSC Pharmaceutical International, Indian Immunologicals Limited, Merck & Co Inc., Novartis International AG, Pfizer Inc., Sanofi SA, Serum Institute of India, Virbac, and Wyeth, LLC.

Market Segmentation & Coverage

This research report categorizes the Human Rabies Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Cell Line Type
    • BHK Cells
    • Chick Embryo Cells
    • Vero Cell
  • Route of Administration
    • Intravenous
    • Subcutaneous
  • Application
    • Post Exposure Prophylaxis
    • Pre Exposure Prophylaxis
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Human Rabies Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Rabies Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Human Rabies Vaccines Market?
  4. What is the market share of the leading vendors in the Human Rabies Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Human Rabies Vaccines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Human Rabies Vaccines Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of mortality due to rabies
5.1.1.2. Increasing number of pets and stray dogs
5.1.1.3. Lower rate of immunization in pets and lack of pet management services
5.1.2. Restraints
5.1.2.1. Dearth of vaccine supply in remote areas
5.1.3. Opportunities
5.1.3.1. Proliferation in research and development activities to introduce effective vaccine
5.1.3.2. Rising entry of new market players in the production of vaccine
5.1.4. Challenges
5.1.4.1. Reduced awareness in emerging economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Human Rabies Vaccines Market, by Cell Line Type
6.1. Introduction
6.2. BHK Cells
6.3. Chick Embryo Cells
6.4. Vero Cell
7. Human Rabies Vaccines Market, by Route of Administration
7.1. Introduction
7.2. Intravenous
7.3. Subcutaneous
8. Human Rabies Vaccines Market, by Application
8.1. Introduction
8.2. Post Exposure Prophylaxis
8.3. Pre Exposure Prophylaxis
9. Human Rabies Vaccines Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Americas Human Rabies Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Human Rabies Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Human Rabies Vaccines Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Bavarian Nordic A/S
14.1.2. Bharat Biotech International Limited
14.1.3. Cadila Pharmaceuticals Ltd.
14.1.4. CSC Pharmaceutical International
14.1.5. Indian Immunologicals Limited
14.1.6. Merck & Co Inc.
14.1.7. Novartis International AG
14.1.8. Pfizer Inc.
14.1.9. Sanofi SA
14.1.10. Serum Institute of India
14.1.11. Virbac
14.1.12. Wyeth, LLC
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. HUMAN RABIES VACCINES MARKET RESEARCH PROCESS
FIGURE 2. HUMAN RABIES VACCINES MARKET SIZE, 2022 VS 2030
FIGURE 3. HUMAN RABIES VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. HUMAN RABIES VACCINES MARKET DYNAMICS
FIGURE 7. HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2022 VS 2030 (%)
FIGURE 8. HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 10. HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 14. HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. HUMAN RABIES VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. HUMAN RABIES VACCINES MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. HUMAN RABIES VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. HUMAN RABIES VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 6. HUMAN RABIES VACCINES MARKET SIZE, BY BHK CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HUMAN RABIES VACCINES MARKET SIZE, BY CHICK EMBRYO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HUMAN RABIES VACCINES MARKET SIZE, BY VERO CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. HUMAN RABIES VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HUMAN RABIES VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. HUMAN RABIES VACCINES MARKET SIZE, BY POST EXPOSURE PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HUMAN RABIES VACCINES MARKET SIZE, BY PRE EXPOSURE PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. HUMAN RABIES VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. HUMAN RABIES VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 55. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 144. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY CELL LINE TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. HUMAN RABIES VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 188. HUMAN RABIES VACCINES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 189. HUMAN RABIES VACCINES MARKET LICENSE & PRICING

Companies Mentioned

  • Bavarian Nordic A/S
  • Bharat Biotech International Limited
  • Cadila Pharmaceuticals Ltd.
  • CSC Pharmaceutical International
  • Indian Immunologicals Limited
  • Merck & Co Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India
  • Virbac
  • Wyeth, LLC

Methodology

Loading
LOADING...

Table Information